Suvretta Capital Management, headquartered in New York, was founded in 2011 by Aaron Cowen. The firm employs a generalist long/short equity strategy, focusing particularly on healthcare and biotechnology industries for its long positions.
Aaron Cowen brings extensive investment experience to Suvretta, having held pivotal roles at renowned hedge funds such as Soros Fund Management and SAC Capital, where he served as a portfolio manager and Chief Investment Officer, respectively. Prior to these roles, he was a partner and managing director at Karsch Capital Management, contributing significantly to the firm's growth to $3.3 billion in assets under management (AUM). Throughout his career, Aaron Cowen has also worked with notable firms including The Baupost Group, Fidelity Investments, and Lehman Brothers. He holds a BS in Finance and a BSE in Bioengineering from the University of Pennsylvania (1994) and an MBA from MIT Sloan School of Management (2002).
As of March 2024, Suvretta Capital Management manages assets for 12 clients, with discretionary assets under management totaling $4,490,893,812. Their Q1 2024 13F filing reported $2,692,637,005 in managed 13F securities, with a top 10 holdings concentration of 44.27%. The SPDR S&P 500 ETF TRUST is their largest holding, with 450,000 shares held.
| Fund Name: | Suvretta Capital Management |
| Manager | Aaron Cowen |
| Portfolio Value | $2,692,637,005 |
| Change This QTR | +1.22% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | SPY | 450,000 | $235,381,500 | NEW | 8.74% | ||
| 2. | Biohaven Ltd | 4,003,046 | $218,926,586 | -13% | 8.13% | ||
| 3. | KURA | 7,069,627 | $150,795,144 | +2% | 5.6% | ||
| 4. | ACLX | 1,562,354 | $108,661,721 | -36% | 4.03% | ||
| 5. | Invesco Qqq TrPUTPUT | 195,000 | $86,581,950 | NEW | 3.21% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2024-05-28 | ||||
| 2024-05-13 | ||||
| 2024-04-29 | ||||
| 2024-04-15 | ||||
| 2024-02-13 |
